Geode Capital Management’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$472K Sell
692,173
-1,717
-0.2% -$1.17K ﹤0.01% 3572
2025
Q1
$632K Buy
693,890
+62,609
+10% +$57K ﹤0.01% 3460
2024
Q4
$688K Buy
631,281
+122,454
+24% +$134K ﹤0.01% 3495
2024
Q3
$385K Buy
508,827
+16,371
+3% +$12.4K ﹤0.01% 3693
2024
Q2
$611K Sell
492,456
-346,075
-41% -$429K ﹤0.01% 3496
2024
Q1
$1.59M Buy
838,531
+25,246
+3% +$47.7K ﹤0.01% 3202
2023
Q4
$2.15M Buy
813,285
+50,864
+7% +$134K ﹤0.01% 3075
2023
Q3
$1.75M Buy
762,421
+32,976
+5% +$75.9K ﹤0.01% 3113
2023
Q2
$2.66M Buy
729,445
+276,677
+61% +$1.01M ﹤0.01% 3022
2023
Q1
$1.62M Buy
452,768
+136,941
+43% +$489K ﹤0.01% 3122
2022
Q4
$900K Buy
315,827
+17,221
+6% +$49.1K ﹤0.01% 3392
2022
Q3
$665K Buy
298,606
+534
+0.2% +$1.19K ﹤0.01% 3584
2022
Q2
$742K Sell
298,072
-250,333
-46% -$623K ﹤0.01% 3554
2022
Q1
$2.68M Buy
548,405
+27,001
+5% +$132K ﹤0.01% 3105
2021
Q4
$5.9M Sell
521,404
-81,008
-13% -$916K ﹤0.01% 2804
2021
Q3
$8.78M Buy
602,412
+86,093
+17% +$1.25M ﹤0.01% 2546
2021
Q2
$6.02M Buy
516,319
+30,270
+6% +$353K ﹤0.01% 2792
2021
Q1
$5.93M Buy
486,049
+55,386
+13% +$676K ﹤0.01% 2703
2020
Q4
$5.39M Buy
430,663
+39,056
+10% +$489K ﹤0.01% 2565
2020
Q3
$5.89M Buy
391,607
+14,369
+4% +$216K ﹤0.01% 2295
2020
Q2
$9.25M Buy
377,238
+68,651
+22% +$1.68M ﹤0.01% 1961
2020
Q1
$4.38M Buy
308,587
+45,381
+17% +$644K ﹤0.01% 2223
2019
Q4
$4.18M Buy
263,206
+52,472
+25% +$833K ﹤0.01% 2571
2019
Q3
$1.78M Buy
210,734
+5,606
+3% +$47.2K ﹤0.01% 3003
2019
Q2
$1.84M Buy
205,128
+58,943
+40% +$530K ﹤0.01% 3003
2019
Q1
$1.13M Buy
146,185
+15,224
+12% +$118K ﹤0.01% 3118
2018
Q4
$615K Buy
130,961
+14,923
+13% +$70.1K ﹤0.01% 3293
2018
Q3
$1.05M Buy
116,038
+6,323
+6% +$57.2K ﹤0.01% 3201
2018
Q2
$1.3M Buy
109,715
+38,481
+54% +$456K ﹤0.01% 3073
2018
Q1
$1M Buy
+71,234
New +$1M ﹤0.01% 3125